CardioGen

Drug BRACCO DIAGNOSTICS INC.
Total Payments
$36,127
Transactions
14
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $19,560 6 5
2018 $16,567 8 4

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $27,963 12 77.4%
Consulting Fee $7,500 1 20.8%
Travel and Lodging $663.83 1 1.8%

Top Doctors Receiving Payments for CardioGen

Doctor Specialty Location Total Records
, MD Internal Medicine New Orleans, LA $17,671 4
, MD, PHD Cardiovascular Disease New Haven, CT $5,501 3
, MD Diagnostic Radiology Roanoke, VA $2,908 1
, M.D Internal Medicine Houston, TX $2,805 1
, MD Diagnostic Radiology Boston, MA $2,664 2
, M.D Cardiovascular Disease Fort Myers, FL $2,529 1
, M.D Nuclear Imaging & Therapy Baltimore, MD $2,050 2

About CardioGen

CardioGen is a drug associated with $36,127 in payments to 7 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is BRACCO DIAGNOSTICS INC..

Payment data is available from 2018 to 2019. In 2019, $19,560 was paid across 6 transactions to 5 doctors.

The most common payment nature for CardioGen is "Honoraria" ($27,963, 77.4% of total).